Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis

(2010) Roland M. du Bois et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

(2010) Brett Ley et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Targeting non-malignant disorders with tyrosine kinase inhibitors

(2010) Friedrich Grimminger et al.   NATURE REVIEWS DRUG DISCOVERY

The pathogenesis of idiopathic pulmonary fibrosis

(2010) William R. Coward et al.   Therapeutic Advances in Respiratory Disease

The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF

(2009) Jeffrey J. Swigris et al.   RESPIRATORY MEDICINE

BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy

(2008) F. Hilberg et al.   CANCER RESEARCH

Outcome measures in the lung

(2008) A. U. Wells et al.   RHEUMATOLOGY